Literature DB >> 31078320

Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis.

Xueqian Zhuang1, Hao Zhang2, Guohong Hu3.   

Abstract

Cancer initiates at one site (primary tumor) and, in most cases, spreads to other distant organs (metastasis). During the multistep process of metastasis, primary tumor cells acquire cellular and phenotypic plasticity to survive and thrive in different environments. Moreover, cancer cells also utilize and educate microenvironmental components by reshaping them into accomplices of metastasis. Recent studies have identified a plethora of new molecular and cellular modulators of metastasis that have dynamic or even opposite roles, dominating the phenotypic plasticity of both tumoral and microenvironmental components. In this review we discuss their bipotential functions and the possible underpinning mechanisms, as well as their implications for targeted cancer therapy.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  bipotential regulators; heterogeneity; metastasis; microenvironment; plasticity

Mesh:

Year:  2019        PMID: 31078320      PMCID: PMC7518789          DOI: 10.1016/j.tips.2019.04.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  86 in total

1.  Mechanism of early dissemination and metastasis in Her2+ mammary cancer.

Authors:  Kathryn L Harper; Maria Soledad Sosa; David Entenberg; Hedayatollah Hosseini; Julie F Cheung; Rita Nobre; Alvaro Avivar-Valderas; Chandandaneep Nagi; Nomeda Girnius; Roger J Davis; Eduardo F Farias; John Condeelis; Christoph A Klein; Julio A Aguirre-Ghiso
Journal:  Nature       Date:  2016-12-14       Impact factor: 49.962

2.  Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.

Authors:  Srinivas Malladi; Danilo G Macalinao; Xin Jin; Lan He; Harihar Basnet; Yilong Zou; Elisa de Stanchina; Joan Massagué
Journal:  Cell       Date:  2016-03-24       Impact factor: 41.582

Review 3.  Regulation of bone mass by Wnt signaling.

Authors:  Venkatesh Krishnan; Henry U Bryant; Ormond A Macdougald
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

4.  The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.

Authors:  Hua Gao; Goutam Chakraborty; Ai Ping Lee-Lim; Qianxing Mo; Markus Decker; Alin Vonica; Ronglai Shen; Edi Brogi; Ali H Brivanlou; Filippo G Giancotti
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

Review 5.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

6.  Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer.

Authors:  Stefan Werner; Sabrina Frey; Sabine Riethdorf; Christian Schulze; Malik Alawi; Lea Kling; Vida Vafaizadeh; Guido Sauter; Luigi Terracciano; Udo Schumacher; Klaus Pantel; Volker Assmann
Journal:  J Biol Chem       Date:  2013-06-29       Impact factor: 5.157

7.  Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

Authors:  Valbona Luga; Liang Zhang; Alicia M Viloria-Petit; Abiodun A Ogunjimi; Mohammad R Inanlou; Elaine Chiu; Marguerite Buchanan; Abdel Nasser Hosein; Mark Basik; Jeffrey L Wrana
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

8.  Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

Authors:  Hao Yin; Wen Xue; Sidi Chen; Roman L Bogorad; Eric Benedetti; Markus Grompe; Victor Koteliansky; Phillip A Sharp; Tyler Jacks; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2014-03-30       Impact factor: 54.908

9.  Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis.

Authors:  Sara Weis; Jianhua Cui; Leo Barnes; David Cheresh
Journal:  J Cell Biol       Date:  2004-10-25       Impact factor: 10.539

10.  Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

Authors:  P Dong; M Karaayvaz; N Jia; M Kaneuchi; J Hamada; H Watari; S Sudo; J Ju; N Sakuragi
Journal:  Oncogene       Date:  2012-07-30       Impact factor: 9.867

View more
  17 in total

Review 1.  SGK1, autophagy and cancer: an overview.

Authors:  Madiha Javeed Ghani
Journal:  Mol Biol Rep       Date:  2021-10-20       Impact factor: 2.316

Review 2.  Centrosome Dynamics and Its Role in Inflammatory Response and Metastatic Process.

Authors:  Massimo Pancione; Luigi Cerulo; Andrea Remo; Guido Giordano; Álvaro Gutierrez-Uzquiza; Paloma Bragado; Almudena Porras
Journal:  Biomolecules       Date:  2021-04-23

3.  Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.

Authors:  Ying Liu; Xingmei Xie; Xuefeng Hou; Junyi Shen; Jiangpei Shi; Haizhen Chen; Yuanzhi He; Zhi Wang; Nianping Feng
Journal:  J Nanobiotechnology       Date:  2020-05-30       Impact factor: 10.435

Review 4.  Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy.

Authors:  Tongyan Liu; Chencheng Han; Siwei Wang; Panqi Fang; Zhifei Ma; Lin Xu; Rong Yin
Journal:  J Hematol Oncol       Date:  2019-08-28       Impact factor: 17.388

5.  hnRNPK-regulated LINC00263 promotes malignant phenotypes through miR-147a/CAPN2.

Authors:  Woo Joo Lee; Chang Hoon Shin; Haein Ji; Seong Dong Jeong; Mi-So Park; Hong-Hee Won; Poonam R Pandey; Dimitrios Tsitsipatis; Myriam Gorospe; Hyeon Ho Kim
Journal:  Cell Death Dis       Date:  2021-03-17       Impact factor: 8.469

6.  Cervical cancer-derived exosomal miR-663b promotes angiogenesis by inhibiting vinculin expression in vascular endothelial cells.

Authors:  Xuewu You; Wenxiong Sun; Ying Wang; Xiaoli Liu; Aihong Wang; Lu Liu; Sai Han; Yu Sun; Junhua Zhang; Lingyu Guo; Youzhong Zhang
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

Review 7.  Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark.

Authors:  Shanshan Zhao; Xue Zhang; Shuo Chen; Song Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-09-14

Review 8.  CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target.

Authors:  Wen Zhang; Huishan Wang; Mingyang Sun; Xueting Deng; Xueru Wu; Yilan Ma; Mengjing Li; Said Maisam Shuoa; Qiang You; Lin Miao
Journal:  Cancer Commun (Lond)       Date:  2020-03

Review 9.  Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer.

Authors:  Milad Ashrafizadeh; Mohammad Reza Bakhoda; Zahra Bahmanpour; Khandan Ilkhani; Ali Zarrabi; Pooyan Makvandi; Haroon Khan; Samaneh Mazaheri; Maryam Darvish; Hamed Mirzaei
Journal:  Front Chem       Date:  2020-10-15       Impact factor: 5.221

Review 10.  Exosomal circRNAs: Emerging Players in Tumor Metastasis.

Authors:  Hao Zhou; Xiaoyun He; Yuxiang He; Chunlin Ou; Pengfei Cao
Journal:  Front Cell Dev Biol       Date:  2021-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.